One Inflation Number Will Set the Tone for the Fed’s December Decision
Wednesday brings PCE, GDP, durable goods and claims before markets shut for Thanksgiving.
Wednesday brings PCE, GDP, durable goods and claims before markets shut for Thanksgiving.
Livsayis wins FDA clearance with a dosing edge, but Alnylam's royalty stream deserves a closer look.
Hunterbrook’s short report doesn’t prove a violation. It prices the risk if licensing tightens.
A record NGS ARR beat, lifted full-year targets, and a $4.5B AI deal hit Wednesday night. Here is why PANW…
Tariff refunds, advertising growth, and e-commerce strength rewrote Q2.
CGON surged 14% on a landmark bladder cancer result, then gave back gains. Here is what investors need to weigh…
CMS’s new CRUSH audit proposal targets Medicare Advantage payments, and UnitedHealth has not yet quantified the exposure.
Xi and Carney signed a trade deal in Shenzhen today, putting about C$400 million in Canadian exports on better terms…
Goldman and Morgan Stanley decide Wednesday evening if $78 still holds.
Phase 3 knee OA results pull obesity drugs into pain coverage.